Convoke: $8.6 Million Secured For Building AI Operating System For Biopharma
By Amit Chowdhry ● Aug 21, 2025
Convoke, an innovative AI-native operating system tailored specifically for the biopharma sector, has successfully secured $8.6 million in seed capital to accelerate its growth and technological development. This financing round was led by the well-established venture capital firms Kleiner Perkins and Dimension Capital, with additional investments from various other firms, including ACME, Comma Capital, Liquid2, Not Boring Capital, Audacious, and Lux Capital. Noteworthy angel investors include prominent figures such as Qasar Younis and Erik Torenberg, alongside other influential leaders in both artificial intelligence and biotechnology.